Lee Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-167
Closed -$9.65K 247
2023
Q4
$9.65K Hold
167
﹤0.01% 437
2023
Q3
$8.82K Hold
167
﹤0.01% 429
2023
Q2
$9.03K Hold
167
﹤0.01% 423
2023
Q1
$8.36K Sell
167
-20
-11% -$943 ﹤0.01% 451
2022
Q4
$8.65K Sell
187
-52
-22% -$2.25K ﹤0.01% 484
2022
Q3
$9K Buy
239
+177
+285% +$7.1K ﹤0.01% 450
2022
Q2
$3K Buy
62
+20
+48% +$814 ﹤0.01% 613
2022
Q1
$2K Hold
42
﹤0.01% 621
2021
Q4
$2K Hold
42
﹤0.01% 713
2021
Q3
$2K Buy
+42
New +$1.86K ﹤0.01% 595
2021
Q1
Sell
-50
Closed -$2K 486
2020
Q4
$2K Buy
+50
New +$1.8K ﹤0.01% 444
2018
Q2
Sell
-40
Closed -$1K 779
2018
Q1
$1K Buy
+40
New +$1.09K ﹤0.01% 720

Other funds holding BSX

Lee Financial's BSX Position: Q1 2024 in Review

Lee Financial sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 167 shares — an estimated $9.65K sold.

Lee Financial first reported a position in BSX in Q1 2018 and held it in 12 quarters. The position peaked at $9.65K in Q4 2023. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Lee Financial reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
  • Lee Financial sold 167 Boston Scientific shares in Q1 2024, an estimated $9.65K.
  • Lee Financial first reported a position in Boston Scientific in Q1 2018 and held it in 12 quarters.
  • Lee Financial's Boston Scientific position peaked at $9.65K in Q4 2023.
  • 1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.